Glooko

Diabnext is a digital diabetes management company based in Paris, Ile-de-France, that offers a comprehensive application designed to enhance the management of pre-diabetes and diabetes. The application automatically monitors insulin and blood glucose levels, facilitating the recording of these metrics in a self-monitoring logbook. By combining hardware and software, Diabnext provides a solution that enhances the accuracy and efficiency of patient education and monitoring. The platform enables both patients and healthcare professionals to access vital data, allowing for improved tracking and management of diabetes. With features such as injection follow-ups, reminders for blood glucose checks, and medication adherence, Diabnext aims to reduce the medico-economic burden associated with diabetes-related complications while promoting better health outcomes for patients.

xbird is a provider of software solutions in the healthcare sector, founded in Berlin in 2015. The company uses artificial intelligence to personalize therapies for better results. Especially in diabetes therapy, the algorithms developed by xbird can record the behavior and lifestyle of patients using smartphones and other wearables. In this way, as part of holistic care, health risks can be identified and prevented and long-term treatment can be optimized.

Diasend simplifies life for people with diabetes and facilitates the work of their health care providers by optimizing diabetes data management. The company’s comprehensive and market leading solution involves transmitting, storing and analyzing data from more than 140 different glucose meters, insulin pumps, CGM systems and leading activity trackers – allowing patients and caregivers to easily access the exact same information. Diasend’s products and services, all FDA approved and CE marked, are currently used in 23 countries. Headquarters are located in Gothenburg, Sweden – with subsidiaries in Chicago and London.

Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.